Cita APA

Suarez-Calvet, M., Kleinberger, G., Caballero, M., Brendel, M., Rominger, A., Alcolea, D., . . . Haass, C. (2016). sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.

Citación estilo Chicago

Suarez-Calvet, M., et al. STREM2 Cerebrospinal Fluid Levels Are a Potential Biomarker for Microglia Activity in Early-stage Alzheimer's Disease and Associate With Neuronal Injury Markers. 2016.

Cita MLA

Suarez-Calvet, M., et al. STREM2 Cerebrospinal Fluid Levels Are a Potential Biomarker for Microglia Activity in Early-stage Alzheimer's Disease and Associate With Neuronal Injury Markers. 2016.